|
|||||
|
|
| 加强企业监测促进公众健康 | |
| 引用本文： | 耿凤英,杨悦,杨月明,金丹,杨华,马辉.加强企业监测促进公众健康[J].中国药物警戒,2008,5(4). |
| 作者姓名： | 耿凤英 杨悦 杨月明 金丹 杨华 马辉 |
| 作者单位： | 1. 沈阳药科大学工商管理学院,辽宁,沈阳,110016;辽宁省药品不良反应监测中心,辽宁,沈阳,110003 2. 沈阳药科大学工商管理学院,辽宁,沈阳,110016 3. 辽宁省药品不良反应监测中心,辽宁,沈阳,110003 |
| 摘 要： | 药品生产、经营企业作为基层报告单位,应加强生产、流通环节的药品不良反应监测工作,及时发现上市后药品的安全性问题,更好地保障公众安全合理用药。 |
| 关 键 词： | 药品不良反应监测 药品企业 |
Strengthening Monitoring of Enterprises to Promote Public Health |
|
| GENG Feng-ying,YANG Yue,YANG Yue-ming,JIN Dan,YANG Hua,MA Hui School of Business Administration,Shenyang Pharmaceutical University.Strengthening Monitoring of Enterprises to Promote Public Health[J].Chinese JOurnal of Pharmacovigilance,2008,5(4). | |
| Authors: | GENG Feng-ying YANG Yue YANG Yue-ming JIN Dan YANG Hua MA Hui School of Business Administration Shenyang Pharmaceutical University |
| Affiliation: | GENG Feng-ying1,2,YANG Yue1,YANG Yue-ming2,JIN Dan2,YANG Hua2,MA Hui2 1School of Business Administration,Shenyang Pharmaceutical University |
| Abstract: | Pharmaceutical enterprises is basic reporting unit that should strengthen ADR monitoring on manufacture and distribution to ensure the safety of post-market drugs. |
| Keywords: | adverse drug reaction monitoring pharmaceutical enterprises |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ | |
